MS clinical trials network launch event programme

3,336 views

Published on

MS Society, Clinical Trials Network, CTN, multiple sclerosis

Published in: Health & Medicine, Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
3,336
On SlideShare
0
From Embeds
0
Number of Embeds
2,770
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

MS clinical trials network launch event programme

  1. 1. MS Clinical Trials Network Launch Event Programme Holiday Inn London Bloomsbury, Coram Street, London, WC1N 1HT 6 CPD points available Monday 7 April 2014 10.00 - 10.30 Registration and Refreshments 10.30 – 10.50 Opening Address Dr Sue Pavitt, Chair of CTN Steering Group 10.50 – 11.20 Introduction to James Lind Alliance Priorities & MS-SMART MS Society 11.20 – 13.20 Parallel Sessions A. Which treatments are effective for fatigue in people with MS? Chair: Dr Jeremy Chataway, National Hospital for Neurology and Neurosurgery, Queen Square Invited Speakers: What is fatigue?: Professor Rona Moss-Morris, Institute of Psychiatry, King's College London Can we measure fatigue?:Professor Jeremy Hobart, University of Plymouth FACETS research programme: Dr Sarah Thomas, Poole Hospital NHS Foundation Trust Implementation of FACETS in the clinical setting: Susan Hourihan
  2. 2. B. Does early treatment with aggressive DMDs improve the prognosis for people with MS? Chair: Professor David Miller, Institute of Neurology, UCL Invited Speakers: Lessons from long-term alemtuzumab treatment: what we know and don’t know? Dr. Alasdair Coles, University of Cambridge Stratified medicine: Dr Peter Connick, University of Edinburgh Escalating Trial Design: Dr Nikos Evangelou, Queens Medical Centre, Nottingham Hospitals NHS Trust Cladribine vs alemtuzumab trial proposal: Dr Klaus Schmierer, Queen Mary University of London C. Is Vitamin D Supplementation an effective Disease Modifying treatment for MS? Chair: Professor Siddharthan Chandran, University of Edinburgh Invited Speakers Learning from Vitamin D trial success in cardiology: Dr Klaus Witte, University of Leeds Professor Gavin Giovannoni, Barts and the London NHS Trust 13.20 – 14.20 Networking Lunch
  3. 3. 14.20 – 14.50 Presentation and Q&A session: Which treatments are effective for fatigue in people with MS? Speaker: Dr Jeremy Chataway, National Hospital for Neurology and Neurosurgery, Queen Square 14.50 – 15.20 Presentation and Q&A session: Does early treatment with aggressive DMDs improve the prognosis for people with MS? Speaker: Professor David Miller, Institute of Neurology, UCL 15.20 – 15.50 Presentation and Q&A session: Is Vitamin D Supplementation an effective Disease Modifying treatment for MS? Speaker: Professor Siddharthan Chandran, University of Edinburgh 15.50 – 16.00 Closing remarks Speaker: Dr Sue Pavitt, Chair of MS CTN Steering Group 16.00 Close of event 16.30 – 17.30 CLOSED SESSION CTN Steering Group Meeting

×